|
Volumn 111, Issue 6, 2013, Pages 984-987
|
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer
|
Author keywords
BCG; bladder cancer; immunosuppression
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
BCG VACCINE;
BLEOMYCIN;
CISPLATIN;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DEXAMETHASONE;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
LENALIDOMIDE;
METHOTREXATE;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OXALIPLATIN;
OXYGEN;
PACLITAXEL;
PEMETREXED;
PREDNISONE;
PROCARBAZINE;
RITUXIMAB;
STEROID;
TACROLIMUS;
VINBLASTINE;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADJUVANT THERAPY;
ARTICLE;
BACTERIAL INFECTION;
BREAST CANCER;
CANCER MORTALITY;
CANCER RECURRENCE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
COLON CANCER;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
EMPHYSEMA;
FOLLOW UP;
GRAFT REJECTION;
HAIRY CELL LEUKEMIA;
HODGKIN DISEASE;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
LUNG NON SMALL CELL CANCER;
LUPUS VULGARIS;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
NON MUSCLE INVASIVE BLADDER CANCER;
NONHODGKIN LYMPHOMA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RECURRENCE FREE SURVIVAL;
RENAL REPLACEMENT THERAPY;
RETREATMENT;
RHEUMATOID ARTHRITIS;
SEPSIS;
TRANSITIONAL CELL CARCINOMA;
TRANSURETHRAL RESECTION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRAVESICAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BCG VACCINE;
CYSTECTOMY;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSION;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
TRANSPLANTS;
URINARY BLADDER NEOPLASMS;
|
EID: 84876890273
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/j.1464-410X.2012.11778.x Document Type: Article |
Times cited : (35)
|
References (5)
|